Chlamydia antigens and corresponding dna fragments and uses thereof
CA 2348827 A1 · Owner: Murdin, Andrew D. · Inventors: Wang, Joe; Oomen, Raymond P.; Murdin, Andrew D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides purified and isolated polynucleotide molecules that encode Chlamydia polypeptides which can be used in methods to prevent treat, and diagnose Chlamydia infection. In one form of the invention the , polynucleotide molecules are selected from DNA that encode polypeptides CPN100397 (SEQ ID Nos: 1 and 2), CPN100421 (SEQ ID Nos: 3 and 4) CPN100422 , (SEQ ID Nos: 4 and 6), CPN100424 (SEQ ID Nos: 7 and 8) CPN100426 (SEQ ID Nos: , 9 and 10), CPN100508 (SEQ ID Nos: 11 and 12) CPN100515 (SEQ ID Nos: 13 and , 14), CPN100538 (SEQ ID Nos: 15 and 16) CPN100557 (SEQ ID Nos: 17 and 18), CPN100622 (SEQ ID Nos: 19 and 20) CPN100626 (SEQ ID Nos: 21 and 22), CPN100628 (SEQ ID …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 28, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 28, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 28, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.